Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Lilly to Invest $1 Billion to Build New Parenteral Manufacturing Facility in North Carolina

February 02, 2022

Eli Lilly and Company is investing $1 billion to establish a new manufacturing site in Concord, NC, to manufacture parenteral products and devices.

Cytiva Provides Arranta Bio with Single-Use Manufacturing Platform for mRNA Products

February 01, 2022

Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.

Spray Drying Finds Growing Use for ASDs

February 01, 2022

CDMOs offer expertise and capacity for spray drying.

Samsung Biologics to Acquire Full Ownership of Samsung Bioepis in $2.3 Billion Deal

January 28, 2022

Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.

Catalent Expands its High Potency Micronization Capabilities in both US and UK

January 28, 2022

Catalent has expanded its Malvern, Pennsylvania, USA, and Dartford, UK, facilities to provide advanced containment capabilities for the micronization of highly potent drug compounds.

Drug Solutions Podcast: 2022 Bio/pharma Trends: US-Based Suppliers, Digitization, and Sustainability

January 18, 2022

In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.

Sustainable Shippers for Ultra-Cold Conditions

January 17, 2022

Protective external packaging ensures COVID-19 vaccines arrive safely.

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System

January 11, 2022

The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.

Clinical Trial on Intranasal Coronavirus Vaccine Set to Start

January 07, 2022

Intravacc is partnering with Leiden University Medical Center for the development and evaluation of a new intranasal coronavirus vaccine candidate in a clinical Phase I/II study.

Addressing the Training Gap for Single-Use Technologies

January 03, 2022

Workforce training is crucial for biopharmaceutical manufacturing.